Ji et al. conducted a follow-up study on 94 ACPA-negative RA patients who met the 2010 ACR/EULAR criteria for RA and found that 65 of them received an alternate diagnosis by the end of the first year. This evidence concerns the gene PRTN3 and rheumatoid arthritis.